Allianz Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
BCM
RIM
RCMC
Allianz Asset Management's IRMD Position: Q2 2024 in Review
Allianz Asset Management sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 22,854 shares — an estimated $1.01M sold.
Allianz Asset Management first reported a position in IRMD in Q3 2015 and held it in 7 quarters. The position peaked at $1.92M in Q4 2015. 139 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.
- Allianz Asset Management reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
- Allianz Asset Management sold 22,854 iRadimed shares in Q2 2024, an estimated $1.01M.
- Allianz Asset Management first reported a position in iRadimed in Q3 2015 and held it in 7 quarters.
- Allianz Asset Management's iRadimed position peaked at $1.92M in Q4 2015.
- 139 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.
Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.